Next |
home / stock / aldr / aldr message board
Subject | By | Source | When |
---|---|---|---|
Hummm :-) | WovenO2 | investorshub | 12/17/2018 4:44:20 PM |
big volume past few days | Verstappenbull | investorshub | 03/21/2018 9:35:07 PM |
whats going on here? | Verstappenbull | investorshub | 03/21/2018 9:35:02 PM |
:-) | WovenO2 | investorshub | 01/23/2018 10:13:20 PM |
POW POW BOOM | WovenO2 | investorshub | 01/08/2018 1:40:19 PM |
Dropping fast Offering Coming ! The offering | stock1ace1 | investorshub | 07/14/2017 5:02:16 PM |
The offering is expected to close on July | stock1ace1 | investorshub | 07/14/2017 12:37:00 PM |
Great Short Here $9.40 Offering coming ! 9k out | stock1ace1 | investorshub | 07/14/2017 12:19:25 PM |
* * $ALDR Video Chart 07-13-17 * * | ClayTrader | investorshub | 07/13/2017 9:21:48 PM |
Almost ready to buy. Many thanks to the overreactors!!! | Cboneofenglewood | investorshub | 07/07/2017 6:46:45 PM |
https://seekingalpha.com/article/4084528-alder-phase-3-migraine-data-points-majo | Inoviorulez | investorshub | 06/28/2017 8:29:35 PM |
out at 13.80 thanks ald | Poor Trader | investorshub | 06/28/2017 12:05:31 PM |
good trade what do you think it will do | Poor Trader | investorshub | 06/28/2017 11:58:26 AM |
I sold that same day for $15, which | T695 | investorshub | 06/28/2017 11:50:02 AM |
took 13.70 long for a trade | Poor Trader | investorshub | 06/28/2017 11:48:30 AM |
In at $14 for the bounce | T695 | investorshub | 06/27/2017 1:11:07 PM |
Valuation analyses show Alder Biopharmaceuticals is highly undervalued... | ValueInvestor15 | investorshub | 10/27/2016 3:17:05 PM |
Alder Reports Positive Top-Line 24-Week Data Demonstrating Persistent | Investor100 | investorshub | 07/25/2016 7:36:53 PM |
$ALDR @ Stockcharts | Investor100 | investorshub | 04/15/2016 12:17:36 PM |
Nice 6% gainer today!!! | Investor100 | investorshub | 04/13/2016 11:29:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Alder BioPharmaceuticals Inc. Company Name:
ALDR Stock Symbol:
NASDAQ Market:
Alder BioPharmaceuticals Inc. Website:
Biotech is in the doldrums. The SPDR S&P Biotech ETF declined 18% in the past six months, and money continues to flow out of the sector. While several biotechs managed to IPO in September and October , it's not all roses. ADC Therapeutics pulled its plans to list citing market...
BOTHELL, Wash., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing therapeutic antibodies for the treatment of migraine, today announced dosing of the first patient in a Phase 1 clinical study to evaluate ALD191...
Shares of Alder Biopharmaceuticals (NASDAQ: ALDR) jumped 111% in September, according to data provided by S&P Global Market Intelligence , after the biotech said it will be acquired by Lundbeck. Lundbeck, a fairly large drugmaker in Denmark, is after Alder Pharmaceuticals' migraine m...